Create Alert
Watchlist

Shilpa Medicare

₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Fundamentals

Market Cap₹8,277Cr
ROE3.77%
P/E Ratio(TTM)74.50
EPS(TTM)11.36
P/B Ratio3.49
Dividend Yield0.12%
Industry P/E34.34
Book Value242.58
Debt to Equity0.25
Face Value1
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Shilpa Medicare

Shilpa Medicare Limited is an India-based pharmaceutical company. The Company is engaged in research and development, manufacturing and sale of oncology drugs and formulations. Its products consist of oncology and non-oncology active pharmaceutical ingredients (APIs), oncology formulations, biosimilars, ophthalmic, oral dissolving films, biochemical diagnostics, organic intermediates, pilot and production scales and transdermal patches. It supplies oncology APIs and intermediates. Its oncology/non-oncology APIs include Capecitabine, Gemcitabine Hydrochloride, Axitinib, Erlotinib HCL, and Irinotecan HCL Trihydrate for various regulated markets, including United States of America, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets. Its non-oncology APIs products include Ambroxol (Mucolytic agent) in Europe and Tranexmic Acid and Ursodeoxycholic acid in India. It is also engaged in manufacturing and sale of Lenvatinib Capsules under the brand name Lenshil.;
Parent OrganisationShilpa Medicare Limited
Managing DirectorMr. Vishnukant Bhutada
NSE SymbolSHILPAMED

Shareholding Pattern

Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Promoters
44.23%
Retail And Others
37.12%
Foreign Institutions
11.20%
Mutual Funds
4.05%
Other Domestic Institutions
3.41%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Torrent Pharmaceuticals
NA
(0.00%)
60.16
Ajanta Pharma
NA
(0.00%)
33.30
Gland Pharma
NA
(0.00%)
39.94
Eris Lifesciences
NA
(0.00%)
63.30